Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, May 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 3 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 37 Mendeley

Summary Patents Wikipedia

So far, Altmetric has seen 3 patents that reference this research output.

METHODS OF TREATING CNS TUMORS WITH TESETAXEL

Application EP-3866782-A4

European Patent Office

METHODS OF ADMINISTERING TESETAXEL WITH CYP3A4 INHIBITORS

Application WO-2022197290-A1

World Intellectual Property Organisation (WIPO)

TAXANE COMPOUNDS, COMPOSITIONS AND METHODS

Application WO-2013162922-A1

World Intellectual Property Organisation (WIPO)